How do CNS-penetrant properties affect JAK inhibitor efficacy in spinal cord versus brain inflammation?

neuropharmacology open
Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
—
Novelty
—
Mechanistic
—
Druggability
—
Priority
70%
Importance
—
Tractability
—
Market price
50%

Description

The debate identified blood-brain barrier penetration as critical for JAK inhibitors but didn’t resolve whether spinal cord pharmacokinetics differ from brain tissue. This anatomical specificity question directly impacts drug development priorities for myelopathy treatments.

Source: Debate session sess_SDA-2026-04-08-gap-pubmed-20260406-062111-db808ee9 (Analysis: SDA-2026-04-08-gap-pubmed-20260406-062111-db808ee9)